Data / Crowdfunding / Texas / BioPact Cellular Transport, Inc.
BioPact Cellular Transport, Inc.: crowdfunding raise on Equifund Crowd Funding Portal Inc., $20,000 to $1,070,000 (2020)
BioPact Cellular Transport, Inc., a corporation in Austin, TX, filed a Form C with the SEC on October 13, 2020 to raise $20,000 to $1,070,000 in common stock through Equifund Crowd Funding Portal Inc.. The offering closed on February 12, 2021. In its most recent fiscal year it reported $0 in revenue and a net loss of $163,296, with 2 employees.
SpecStream is the live web data engine for teams and agents. It reads every Form C on SEC EDGAR each morning, and this page is that reading. Ask for your own cut (a portal, a state, a size, a revenue range) and new raises arrive in your sheet, CRM, Slack or agent as they land.
- Website
- biopactct.com
- Funding portal
- Equifund Crowd Funding Portal Inc.
- Address
- 13477 Fitzhugh Road, Austin, TX 78736
- Legal form
- Corporation
- Jurisdiction
- NV
- Incorporated
- August 28, 2019
- SEC CIK
- 0001797565
Offering terms
From the amendment filed October 13, 2020.
- Security
- Common Stock
- Price
- $1.55
- Target
- $20,000
- Maximum
- $1,070,000
- Deadline
- February 12, 2021
- Portal compensation
- The Intermediary will receive a commission equal to seven percent (7%) of the amount raised in the offering.
Financials
From the Form C-AR filed October 1, 2025.
| Most recent fiscal year | Prior fiscal year | Source | |
|---|---|---|---|
| Revenue | $0 | $0 | sec.gov |
| Cost of goods sold | $0 | $0 | sec.gov |
| Net income | $-163,296 | $-368,065 | sec.gov |
| Taxes paid | $0 | $0 | sec.gov |
| Total assets | $19,705 | $19,070 | sec.gov |
| Cash | $9,615 | $6,738 | sec.gov |
| Accounts receivable | $0 | $0 | sec.gov |
| Short-term debt | $621,138 | $507,629 | sec.gov |
| Long-term debt | $0 | $0 | sec.gov |
Filings
| Filed | Filing | Target | Maximum | Deadline | Note | Source |
|---|---|---|---|---|---|---|
| July 1, 2026 | Termination of reporting | Not listed | Not listed | sec.gov | ||
| October 1, 2025 | Annual report | Not listed | Not listed | sec.gov | ||
| May 16, 2024 | Annual report | Not listed | Not listed | sec.gov | ||
| May 4, 2023 | Annual report | Not listed | Not listed | sec.gov | ||
| May 4, 2023 | Annual report | Not listed | Not listed | sec.gov | ||
| May 26, 2021 | Progress update | $20,000 | $1,070,000 | June 30, 2020 | This Form C-U shall serve as an update regarding the offering that ended February 12, 2021. The final accounting indicates that the total amount raised was $1,036,209.10. | sec.gov |
| April 30, 2021 | Annual report | Not listed | Not listed | sec.gov | ||
| October 13, 2020 | Amendment | $20,000 | $1,070,000 | February 12, 2021 | Amendment to Offering Statement | sec.gov |
| June 26, 2020 | Amendment | $20,000 | $1,070,000 | February 12, 2021 | This Amendment is filed to extend the Offering deadline to February 21, 2021 and to disclose the six month extension of the Company's $200,000 promissory note issued to its affiliate, BioPact Ventures, LLC. | sec.gov |
| February 12, 2020 | Offering | $20,000 | $1,070,000 | June 30, 2020 | sec.gov |
Updated July 1, 2026. Read from SEC EDGAR. Public domain (U.S. government work). Financials are as each company reported them in its Form C, unaudited unless the filing says otherwise. Websites are the ones the companies declared to the SEC. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.